Skip to main content

Smarter Bioprocessing Starts Here: Explore the Cytiva x Culture Global Collaboration

nav_banner-logos
Login
Contact

About Us

We're innovating technology to eliminate the bottlenecks in bioprocessing

"Culture is revolutionizing upstream bioprocess development with cloud-native software that makes data accessible, contextualized, and actionable—unlocking the full potential of AI and machine learning in bioprocessing."

Chris Williams 1591458715971
Chris Williams

CEO, Culture Biosciences

Where we’ve been, and
where we’re going

console

Console

With the goal of making bioprocess development as easy as possible, we designed ConsoleTM to be an intuitive way for scientists to design and analyze their experiments from the web.

250-small

250mL bioreactor

Our 250 mL bioreactor was designed for fed-batch microbial and fermentation processes. We manufactured and scaled out these reactors to accommodate a growing customer base of therapeutics and synthetic biology customers.

2018
5l-small

5L bioreactor

After listening to our customers, we heard that their biggest need was material for process development. We launched our 5L reactors to enable large-batch material generation.

2022
Stratyx

Stratyx™ 250

Building on the success of our 250mL and 5L bioreactors, Stratyx 250™ represents the next evolution in cloud-integrated bioprocessing, right in the hands of our users.

2025
Leadership

Leadership

Victor Bornsztejn
Victor Bornsztejn
Senior Vice President of Commercial
Chris-Williams
Chris Williams
Chief Executive Officer
Babu Sivaraman
Babu Sivaraman
Senior Vice President of Product and R&D
Lauren Kellogg
Lauren Kellogg
Vice President of Strategy & Corporate Development
Scott Greenstone
Scott Greenstone
Senior Vice President, Finance
Barbara Weaver
Barbara Weaver
Director, Human Resources

Board of Directors

Chris-Williams
Chris Williams
Chief Executive Officer
Andrew Lee
Andrew Lee
Principal at Northpond Ventures
Shivani Oberoi
Shivani Oberoi
Investment Principal at Synthesis Capital
Dan Phillips
Dan Phillips
Partner of Cultivian Sandbox and Sandbox Sustainability Ventures at Sandbox Industries
William Patrick
William Patrick
Co-Founder, Culture Biosciences
Beth Thompson-Webb
Beth Thompson-Webb
Chief Commercial Officer, Virica Biotech
Nick Futrell
Nick Futrell (Observer)
Senior Associate at Northpond Ventures
Costa Yiannoulis
Costa Yiannoulis (Observer)
Co-founder and Managing Partner of Synthesis Capital

Advisory Board

Joydeep Ganguly
Joydeep Ganguly
Chief Operations & Quality Officer, Agilent Technologies
Bob Todd
Bob Todd, PhD
Digital Process Design Pioneer and former Senior Vice President, Technology and Innovation at KBI Pharma
Phil Vanek
Phil Vanek, PhD
Chief Technology Officer at Gamma Biosciences
Eliana Clark
Eliana Clark PhD
Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc.
Learn more

We’ve partnered with Cytiva to give customers confidence that the process and data produced from Culture’s ecosystem will help them predict performance at the next level, whether it be clinical or commercial scale.

Grow with
Culture

View Careers
grow-w-culture